Precision Medicine Programs Can Attain ROI Sooner Than Some Naysayers Maintain
Focusing on the right factors can accelerate a precision medicine program’s ROI...
Read More Hospitals Hit with Readmission Penalties; Some of Those Not Hit Used Precision Medicine in Strategy
As CMS announces readmission penalties for nearly 2,600 hospitals, some hospitals and health systems are finding precision medicine and big data efforts to be a new strategy for reducing 30-day readmissions...
Read More UCSF Steps Up Biobanking Program Efforts, Naming Its First Chief Biobank Officer
Analysts predict that the global tissue banking market will grow to nearly $3 billion by 2026. Health executives at UCSF have recognized this trend and are executing on plan to attract patients and funding, and ultimately improve outcomes...
Read More Hospital CEOs: McKinsey says “Hospitals Are Dead. Long Live the Hospital”
Trends affecting hospitals and health systems worldwide are forcing them to alter how they are structured and how they deliver care. Here’s how precision medicine factors in...
Read More Independent and Rural Hospitals Closing at Record Rates, Vulnerable Patients at Risk of Missing Out on Precision Medicine’s Potential
Studies by KHN, Navigant, and others report that independent rural hospitals are closing at record rates, leaving patients without critical nearby healthcare services, including precision medicine’s benefits...
Read More Answer These Questions Before Embarking on a Precision Medicine Journey
Temple University All of Us lead investigators discuss the clinical and business reasons and community impact of joining the NIH precision medicine research project...
Read More Do Multigene Panels Offer Cancer Patients, Payers More Value?
Daryl Pritchard, PhD, discusses the untapped potential of multi-gene panel sequencing and targeted therapies for patients with advanced cancer....
Read More Why the Cleveland Clinic Uses Telegenetics, Chatbots to Address Genetic Cancer Risk
Charis Eng, MD, PhD, explains how the Cleveland Clinic is overcoming workforce challenges in clinical cancer genetics...
Read More Bridging the Gap Between the Clinical Possibilities and Economics of Precision Medicine
From research and development to pricing and access, the discourse on precision medicine is expanding, reflecting the emergence of new and multiple ideas of precision medicine aims in relation to healthcare economics, payment models, and patient outcomes...
Read More